Annual report [Section 13 and 15(d), not S-K Item 405]

Significant Accounting Policies - Revenue Recognition (Details)

v3.26.1
Significant Accounting Policies - Revenue Recognition (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
customer
Significant Accounting Policies        
Revenue     $ 1,459,080 $ 1,500,455
Number of customers (customer) | customer       4
Revenue | Product Concentration Risk        
Significant Accounting Policies        
Percentage of total revenue (as a percent) 100.00% 100.00%    
Capitated Revenue [Member]        
Significant Accounting Policies        
Revenue     $ 1,428,979 $ 1,483,602
Capitated Revenue [Member] | Revenue | Product Concentration Risk        
Significant Accounting Policies        
Percentage of total revenue (as a percent)     97.90% 98.90%
Health Care, Other [Member]        
Significant Accounting Policies        
Revenue     $ 30,101 $ 16,853
Health Care, Other [Member] | Revenue | Product Concentration Risk        
Significant Accounting Policies        
Percentage of total revenue (as a percent)     2.00% 1.10%
Clinical fees & insurance revenue        
Significant Accounting Policies        
Revenue     $ 3,056 $ 5,934
Clinical fees & insurance revenue | Revenue | Product Concentration Risk        
Significant Accounting Policies        
Percentage of total revenue (as a percent)     0.20% 0.40%
Care coordination / management fees        
Significant Accounting Policies        
Revenue     $ 10,823 $ 10,563
Care coordination / management fees | Revenue | Product Concentration Risk        
Significant Accounting Policies        
Percentage of total revenue (as a percent)     0.70% 0.70%
Incentive fees and other revenue        
Significant Accounting Policies        
Revenue     $ 16,222 $ 356
Incentive fees and other revenue | Revenue | Product Concentration Risk        
Significant Accounting Policies        
Percentage of total revenue (as a percent)     1.10% 0.00%